01-02-2007 | Lung Cancer
Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors
Published in: Current Treatment Options in Oncology | Issue 1/2007
Login to get access01-02-2007 | Lung Cancer
Published in: Current Treatment Options in Oncology | Issue 1/2007
Login to get access